Retraction: Ke et al. Resveratrol enhances chemosensitivity of renal cell carcinoma to paclitaxel. Frontiers in Bioscience (Landmark Edition). 2019; 24: 1452–1461
- DOI
- 10.31083/fbl37283
- Published
- 2025-01-20
- Container
- Frontiers in Bioscience-Landmark
- Publisher
- IMR Press
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.31083/fbl37283,
title = {Retraction: Ke et al. Resveratrol enhances chemosensitivity of renal cell carcinoma to paclitaxel. Frontiers in Bioscience (Landmark Edition). 2019; 24: 1452–1461},
author = {Frontiers in Bioscience-Landmark Editorial Office},
year = {2025},
journal = {Frontiers in Bioscience-Landmark},
doi = {10.31083/fbl37283},
url = {https://doi.org/10.31083/fbl37283}
}RIS
TY - JOUR TI - Retraction: Ke et al. Resveratrol enhances chemosensitivity of renal cell carcinoma to paclitaxel. Frontiers in Bioscience (Landmark Edition). 2019; 24: 1452–1461 AU - Frontiers in Bioscience-Landmark Editorial Office PY - 2025 JO - Frontiers in Bioscience-Landmark DO - 10.31083/fbl37283 UR - https://doi.org/10.31083/fbl37283 ER -
APA
Office, F. I. B. E. (2025). Retraction: Ke et al. Resveratrol enhances chemosensitivity of renal cell carcinoma to paclitaxel. Frontiers in Bioscience (Landmark Edition). 2019; 24: 1452–1461. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/fbl37283
Source records
- crossref · retrieved 2026-09-25T09:16:29.168Z